ClearPoint Neuro Bags US FDA Nod For Prism Bone Anchor Accessory

ClearPoint Neuro, a global therapy-enabling platform, and quality treatment empowering organization offering exact route to the brain and spine, declared it has secured 510(k) approval for its Prism Bone Anchor Accessory. The company's second new...

Pfizer & Genmab’s Tivdak Bags US FDA Nod to Treat Cervical Cancer

Pfizer Inc, a pharmaceutical industry firm and Genmab A/S reported that the US Food and Drug Administration (FDA) endorses the supplemental Biologics License Application (sBLA) giving full endorsement for Tivdak (tisotumab vedotin-tftv) for the...

Neurocrine Secures FDA Approval of Ingrezza's Sprinkle Capsules

The US FDA endorsed the utilization of a sprinkle case plan of Neurocrine Biosciences Ingrezza (valbenazine) for the treatment of tardive dyskinesia and chorea in Huntington's illness. The US FDA endorsed the utilization of a sprinkle case plan.....

Astellas and Poseida Ink Pact To Develop Novel Allogeneic Cell Therapies

Japanese Astellas Pharma Inc. and Poseida Therapeutics, Inc. declared that Xyphos Biosciences, Inc., and Poseida have gone into a research collaboration and permit consent to foster novel convertibleCAR® programs by consolidating the creative cell...

TriLink BioTech and Lonza Foray into Non-exclusive Supply Agreement

TriLink BioTechnologies, a Maravai LifeSciences company that provides global life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, an international development and manufacturing partner for the...

Bio-Techne Forays Distribution Agreement with Thermo Fisher Scientific

Bio-Techne Enterprise, a biotechnology firm, declare a critical achievement in its obligation to giving state of the art solutions for its users. With effective from May 1, 2024, the firm will foray into an strategic distribution deal with Thermo...

© 2024 India Pharma Outlook. All Rights Reserved.